CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV - Report - MDSpire

CD4/CD8 ratio is associated with structural reorganization of vaccine-induced immune responses in people living with HIV

  • By

  • Faith Jessica Paran

  • Mizue Saita

  • Rieko Oyama

  • Namiko Nomura

  • Kaori Saito

  • Abdullah Khasawneh

  • Pei Gao

  • Songling Li

  • Hendra Saputra Ismanto

  • Noriyo Nagata

  • Naoko Iwata

  • Yasushi Okazaki

  • Tadaki Suzuki

  • Yuki Uehara

  • Kazuhisa Takahashi

  • Daron M Standley

  • Yoko Tabe

  • Toshio Naito

  • June 1, 2026

  • 0 min

Share

Clinical Report: Association of CD4/CD8 Ratio with Vaccine Responses in HIV

Overview

This study investigates the relationship between CD4/CD8 ratio and vaccine-induced immune responses in individuals living with HIV (PLWH). It highlights distinct immune states associated with different CD4/CD8 ratios.

Background

People living with HIV (PLWH) experience persistent immune activation and low-grade inflammation despite effective antiretroviral therapy. The CD4/CD8 ratio is a critical marker of immune health.

Data Highlights

No numerical data or trial data presented in the source material.

Key Findings

  • Stratification by CD4/CD8 ratio revealed distinct immune states in PLWH.
  • Normal CD4/CD8 ratios showed focused transcriptional activation, while low ratios exhibited broad transcriptional dysregulation.
  • Low CD4/CD8 ratio group had increased monocyte-specific protein–protein interaction connectivity.
  • Clonal skewing and reduced clonotype diversity were observed in the low CD4/CD8 ratio group.
  • Vaccine-induced immune responses were influenced by network-level organization associated with CD4/CD8 ratio.

Clinical Implications

The findings suggest that the CD4/CD8 ratio may provide insights into the immune response dynamics following vaccination in PLWH. Clinicians should consider the implications of immune network organization when evaluating vaccine responses in this population.

Conclusion

The study emphasizes the importance of understanding immune network dynamics in PLWH to better interpret vaccine responses and guide clinical decision-making.

Related Resources & Content

  1. Infection, 2026 -- Long-term immune recovery under continuous antiretroviral therapy (ART) among ART-naive people living with HIV in two cohorts in Germany
  2. Open Forum Infectious Diseases, 2021 -- Changes in T-Cell Phenotype Over Time During Extended Antiretroviral Treatment in Individuals Living with HIV
  3. Frontiers in Immunology, 2026 -- IL-18 and MIG increase one year after transition to dolutegravir-based dual therapy despite sustained viral suppression
  4. The Journal of Infectious Diseases, 2021 -- When PD-1 Meets Plaque: Making CD8 Senescence Signals Clinically Actionable in Treated HIV
  5. Adult Immunization Schedule by Medical Condition and Other Indication, CDC, 2025 -- Vaccines & Immunizations
  6. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, 2024
  7. Adult Immunization Schedule by Medical Condition and Other Indication (Addendum updated July 2, 2025) | Vaccines & Immunizations | CDC
  8. Guidelines for the Prevention and Treatment of

Original Source(s)

Related Content